• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Sean Combs set to be released from prison in 2028

admin - Latest News - October 28, 2025
admin
25 views 6 secs 0 Comments



Sean Combs set to be released from prison in 2028



Source link

TAGS:
PREVIOUS
Amazon reportedly laying off 30,000 employees
NEXT
Oct. 28, 2025, 4:35 AM EDTBy Greg RosensteinLOS ANGELES — Freddie Freeman has done it again.One year after hitting the first walk-off grand slam in World Series history, he came through again for the Dodgers with a hit for the ages. Freeman’s solo home run in the 18th inning against the Toronto Blue Jays ended a game tied for the longest in World Series history, propelling Los Angeles to a 6-5 win and a 2-1 series lead.“It’s one of the greatest World Series games of all time,” Dodgers manager Dave Roberts said.Freeman played down the epic nature of his homer to seal a game that officially lasted six hours and 39 minutes. “I was just trying to get on base against a tough lefty, sinkerballer,” Freeman said after the marathon Game 3. “I got it to a 3-2 count and put a good swing on it.” He said he felt “just pure excitement,” adding: “That’s as good as it gets.”The only other World Series matchup to go 18 innings was the Red Sox at Dodgers in 2018. Monday’s game was one of the most unique in baseball history. There were 609 pitches thrown, 19 different pitchers used, 25 position players used and 37 runners left on base.The length was so improbable that Los Angeles starter Yoshinobu Yamamoto — who threw a masterful complete game victory just two nights ago in Toronto — began warming up in the bullpen. While Freeman deserves credit for the decisive blow, his teammate Shohei Ohtani was equally crucial in the victory for the defending champions. The Japanese superstar hit two home runs and two doubles early in the game — and then was intentionally walked four straight times by the Blue Jays, who preferred to face Mookie Betts and Freeman than Ohtani’s hot bat. Ohtani reached base nine times, setting the postseason record and tying the all-time record with only three other batters (the last in 1942). Ohtani was again central to the Dodgers victory.Sean M. Haffey / Getty Images“You just don’t see that type of behavior from opposing managers,” Roberts said of Ohtani being walked throughout the game. “That’s just a sign of respect.” Ohtani, who is also among the best pitchers in baseball, will start on the mound for Los Angeles on Tuesday night at 8 p.m. ET opposite Toronto’s Shane Bieber for Game 4. Ohtani won both of his pitching matchups this postseason, allowing just three earned runs over 12 innings.“He’s a freak. I don’t know how anybody can do what he does,” Dodgers pitcher Will Klein said of Ohtani postgame. “Just getting to be teammates with him is a great honor.” The fact that both teams must suit up mere hours after the last one ended feels improbable. Freeman was mobbed by teammates after hitting the walk-off home run.Harry How / Getty Images“I’m spent emotionally, Roberts said. “We got a ball game later tonight, which is crazy.”Their opponent was determined not to let the gutting loss define the series. “The Dodgers didn’t win a World Series today,” said Blue Jays manager John Schneider. “They won a game.”Now it’s time, somehow, for another.Greg RosensteinGreg Rosenstein is the sports editor for NBC News Digital.The Associated Press contributed.
Related Post
November 19, 2025
Trump defends Saudi crown prince over journalist’s murder
September 24, 2025
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleSept. 24, 2025, 5:49 PM EDT / Updated Sept. 24, 2025, 6:03 PM EDTBy Babak DehghanpishehIranian President Masoud Pezeshkian lashed out at the U.S and Israel for their attacks in June during a speech at the United Nations on Wednesday, one day after Supreme Leader Ayatollah Ali Khamenei, the highest authority in the country, ruled out talks with President Donald Trump about Iran’s nuclear program.“The aerial assaults of [Israel] and the United States of America against Iran’s cities, homes and infrastructure, precisely at a time when we were treading the path of diplomatic negotiations, constituted a grave betrayal of diplomacy and a subversion of efforts towards the establishment of stability and peace,” he said. At the podium, Pezeshkian held up a book with the words “Killed By Israel” printed on the front and leafed through pages with pictures of families and children. There have been calls among moderates in Iran for direct talks with Trump, but on Tuesday Khamenei rejected negotiations with the U.S. about the country’s nuclear program and in many ways set the parameters of what Pezeshkian could discuss in New York.Trump: Iran ‘can never be allowed to possess the most dangerous weapon’01:56“In my view, negotiating with America about the nuclear issue and maybe other issues is an absolute dead end,” Khamenei said in an address, adding that Iran would not stop uranium enrichment because it would not be acceptable to the people of the country, according to his official website. He added, “This negotiation will be beneficial for the current American president. He will hold his head high, say I threatened Iran and I brought them to the negotiating table. He will be proud of this in the world. But for us it’s an absolute loss and has no benefit.”Khamenei also said on Tuesday that Iran does not intend to build a nuclear weapon, a point that Pezeshkian highlighted in his speech Wednesday, and that it will not negotiate on its ballistic missile program.NBC News has reached out to the White House for comment.Khamenei’s remarks came as the Trump administration appeared to be showing a willingness to hold talks. Trump’s Middle East envoy, Steve Witkoff, said Wednesday that Iran is in a tough position and that the administration wants to negotiate with it, according to Reuters.”We’re talking to them,” Witkoff said when asked if there is a diplomatic path forward with Iran.But the hard line drawn by Khamenei against talks with Trump about the nuclear issue could significantly ramp up tensions with the U.S. and Israel.The value of the Iranian rial against the U.S. dollar hit a record low Wednesday after Khamenei’s remarks.Moderate voices in Iran pushing for direct talks with the U.S. were hoping to stave off more devastating attacks on the country by either the Israeli or U.S. military, which pummeled the Fordo, Natanz and Isfahan nuclear sites in late June with airstrikes, including the first combat use of massive “bunker buster” bombs. Trump, addressing the United Nations on Tuesday, said the attacks had targeted “Iran’s key nuclear facility, totally obliterating everything.” But analysts have raised questions about the extent of the damage caused by the attacks and the whereabouts of the approximately 880 pounds of enriched uranium that Iran is thought to have produced.The Israeli attacks, which Israeli officials said were intended to stop the Islamic Republic from obtaining a nuclear weapon, also hammered nuclear targets but expanded to include energy infrastructure and even the country’s notorious Evin prison, and killed more than 1,000 people, according to state media.Even if Iran does not talk to the U.S. directly, Pezeshkian and his foreign minister, Abbas Araghchi, only have until Sep. 27 to negotiate a diplomatic solution with Britain, France and Germany before they face a “snapback” of sanctions. Negotiated under the 2015 nuclear deal, the snapback would lead to an arms embargo, freezing of assets outside the country and restrictions on enriching uranium, among other penalties.The sanctions could hit at a time when the country is reeling from an economic crisis, which critics blame on current sanctions as well as corruption and mismanagement. French President Emmanuel Macron met with Pezeshkian on the sidelines of the U.N. meeting in New York on Wednesday and posted on X that a diplomatic solution to avoid snapback could still be reached if Iran allows full access to inspectors from the International Atomic Energy Agency, is transparent about its stockpile of enriched materials and resumes negotiations. “An agreement remains possible. Only a few hours are left,” Macron wrote. “It is up to Iran to respond to the legitimate conditions we have set.”In recent months, Pezeshkian has been fighting for his political, and actual, life. He narrowly escaped an Israeli attack on a meeting of top officials in June, and his conservative critics have pressed him hard on the economy as well as restrictions on social freedoms. Security forces kicked off a massive crackdown during and after the war. The crackdown was ostensibly to ferret out spies, but in many cases the security forces used the war as a pretext to detain ethnic and religious minorities as well as Afghan migrants, according to Amnesty International. A police spokesman said in mid-August that 21,000 people had been arrested in the 12-day period of the war and observers say that more arrests have subsequently taken place and pending executions have been expedited. “They’re targeting already marginalized groups even further, and that’s one way for them to exert and show the control that they have and try to retain their power while also instilling fear in the population,” said Nassim Papayianni, an Iran campaigner at Amnesty International. “You’re talking about scapegoating. So essentially they are trying to use the conflict as a way to ramp up the crackdown and the arrests.”With Pezeshkian’s hands tied on the international stage by the supreme leader and his hard-line opponents pressing a crackdown on real and perceived enemies at home, the Iranian president appears more isolated than at any point since assuming his position last year. Babak DehghanpishehBabak Dehghanpisheh is an NBC News Digital international editor based in New York.
September 26, 2025
Sept. 26, 2025, 11:24 AM EDTBy Rob Wile and Steve KopackAnalysts are already warning that U.S. consumers could see higher prices due to new tariffs President Donald Trump plans to impose on drug product imports as soon as next week.But a series of exemptions may blunt the ultimate impact. In a Truth Social post late Thursday, Trump said that any branded or patented pharmaceutical products brought into the U.S. would face a 100% tariff starting Oct. 1.U.S. imports of pharmaceuticals totaled about $213 billion in 2024, a threefold increase from a decade earlier, according to data from the United Nations Comtrade Database.With Asia alone accounting for just over 20% of those imports by value, U.S. consumers could see a “meaningful commercial hit,” Louise Loo, head of Asia economics at Oxford Economics research group, said in a note to clients. Previous studies have shown that U.S. annual spending per capita on prescription drugs is about double the rest of the developed world. In July, Trump announced a plan to “get Americans the best prices in the world for prescription drugs” that involved asking major drugmakers to match low prices they offer elsewhere in the world. However, it is not clear what actions the pharma firms have taken to begin addressing that demand. The pharmaceutical industry is already warning that the new tariffs could derail further drug development while also raising prices. “Every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures,” Alex Schriver, senior vice president for PhRMA, the drug industry’s primary lobbying group, said in a statement. “Medicines have historically been exempt from tariffs because they raise costs and could lead to shortages.”Despite those warnings, a significant share of drug products could wind up being exempted from the new import duties. The tariffs do not appear to apply to so-called generic drugs, which account for 9 out of 10 prescriptions filled in the U.S., according to the Food and Drug Administration. The White House did not immediately respond to a request to confirm the exemption for generics, but assuming they will remain tariff-free, the impact to consumers could be more limited than feared. Trump also specified that any drug companies that currently have, or have committed to building, U.S.-based drug-making facilities would be exempted from tariffs. That’s a category that includes numerous major drugmakers. “Many pharmaceutical companies have facilities in the U.S., so it may be relatively easy to superficially expand those facilities to avoid tariffs being applied,” Paul Donovan, chief global economist at UBS Global Wealth Management, wrote in a note to clients. Analysts at JPMorgan agreed: “While there remains very limited details, we note that this will likely lead to a majority of pharma products being excluded from any tariffs” because most major companies have recently increased or have started to increase their U.S. manufacturing facilities.On the White House website, the administration maintains a “running list of new U.S. investment” from private companies. At least 15 pharmaceutical or drug makers are listed with investments ranging from new manufacturing facilities, tens of billions in expanded U.S. production and increased R&D spending. Many of those announcements would appear to meet the requirements laid out by Trump to avoid the new tariff.Two major European drugmakers, Roche and Novartis, said in statements that they expected little to no impact from the newly announced duties. “We are working to ensure that all major Novartis medicines for U.S. patients are manufactured in the U.S.,” Novartis said in a statement. “The announced 100% tariff should not have an impact.” Roche pointed to ongoing factory construction in the U.S., with multiple sites being expanded and upgraded in Kentucky, Indiana, New Jersey and California.Trump has signaled since at least April that drug imports would face tariffs. In anticipation, major drugmakers have indicated they have been stockpiling supplies, analysts said. As a result, consumers are unlikely to feel immediate effects even though the tariffs are set to kick in next week. “We think there may have been significant inventory accumulation this year,” Neil Shearing, group chief economist with Capital Economics, said in a note. This summer, Trump placed a maximum 15% tariff on most pharmaceuticals coming in from the European Union, which accounts for 60% of drugs imported by the U.S. E.U. officials believe that this agreement will shield it from the 100% duties, though they said they could not be certain. “This clear all-inclusive 15% tariff ceiling for E.U. exports represents an insurance policy that no higher tariffs will emerge for European economic operators,” a European Commission spokesperson told NBC News on Friday.Ireland’s deputy prime minister, Simon Harris, who also acts as trade minister, said his country is “studying the impact of this announcement” but added that he believed the 15% cap on pharma tariffs remained in place. Ireland alone accounts for 24% of pharma imports to the U.S.Rob WileRob Wile is a Pulitzer Prize-winning journalist covering breaking business stories for NBCNews.com.Steve KopackSteve Kopack is a senior reporter at NBC News covering business and the economy.
October 6, 2025
CDC signs off on fall Covid shots. It may not be easy to get one, depending on where you live.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved